NIAID Banner Logo Image

HIV Citation List: August 30 - September 12, 2013

PubMed citations

1. Heavy Chain-only IgG2b Llama Antibody Effects Near-Pan HIV-1 Neutralization by Recognizing a CD4-induced Epitope That Includes Elements of Coreceptor- and CD4-binding Sites. Acharya, P., T.S. Luongo, I.S. Georgiev, J. Matz, S.D. Schmidt, M.K. Louder, P. Kessler, Y. Yang, K. McKee, S. O'Dell, L. Chen, D. Baty, P. Chames, L. Martin, J.R. Mascola, and P.D. Kwong. Journal of Virology, 2013. 87(18): p. 10173-10181. PMID[23843638].

[PubMed]. HIV_0830-091213.


2. Vaginal Concentrations of Lactic acid Potently Inactivate HIV. Aldunate, M., D. Tyssen, A. Johnson, T. Zakir, S. Sonza, T. Moench, R. Cone, and G. Tachedjian. The Journal of Antimicrobial Chemotherapy, 2013. 68(9): p. 2015-2025. PMID[23657804].

[PubMed]. HIV_0830-091213.


3. Progesterone and a Phospholipase Inhibitor Increase the Endosomal bis(Monoacylglycero)phosphate Content and Block HIV Viral Particle Intercellular Transmission. Chapuy-Regaud, S., C. Subra, M. Requena, P. de Medina, S. Amara, I. Delton-Vandenbroucke, B. Payre, M. Cazabat, F. Carriere, J. Izopet, M. Poirot, and M. Record. Biochimie, 2013. 95(9): p. 1677-1688. PMID[23774297].

[PubMed]. HIV_0830-091213.


4. The PKR Activator, PACT, Becomes a PKR Inhibitor During HIV-1 Replication. Clerzius, G., E. Shaw, A. Daher, S. Burugu, J.F. Gelinas, T. Ear, L. Sinck, J.P. Routy, A.J. Mouland, R.C. Patel, and A. Gatignol. Retrovirology, 2013. 10(1): p. 96. PMID[24020926].

[PubMed]. HIV_0830-091213.


5. Characterization of Permeability, Stability and anti-HIV-1 Activity of Decitabine and Gemcitabine Divalerate Prodrugs. Clouser, C.L., L. Bonnac, L.M. Mansky, and S.E. Patterson. Antiviral Chemistry & Chemotherapy, 2013. [Epub ahead of print]. PMID[23994876].

[PubMed]. HIV_0830-091213.


6. Highly Potent HIV-1 Protease Inhibitors with Novel Tricyclic P2 Ligands: Design, Synthesis, and Protein-ligand X-ray Studies. Ghosh, A.K., G.L. Parham, C.D. Martyr, P.R. Nyalapatla, H.L. Osswald, J. Agniswamy, Y.F. Wang, M. Amano, I.T. Weber, and H. Mitsuya. Journal of Medicinal Chemistry, 2013. 56(17): p. 6792-6802. PMID[23947685].

[PubMed]. HIV_0830-091213.


7. Modular Construction of Quaternary Hemiaminal-based Inhibitor Candidates and Their in Cellulo Assessment with HIV-1 Protease. Gros, G., L. Martinez, A.S. Gimenez, P. Adler, P. Maurin, R. Wolkowicz, P. Falson, and J. Hasserodt. Bioorganic & Medicinal Chemistry, 2013. 21(17): p. 5407-5413. PMID[23911197].

[PubMed]. HIV_0830-091213.


8. Interferon Alfa Partially Inhibits HIV Replication in Hepatocytes in Vitro. Kong, L. and J.T. Blackard. The Journal of Infectious Diseases, 2013. 208(5): p. 865-866. PMID[23757338].

[PubMed]. HIV_0830-091213.


9. Inhibition of CXCR4 Expression by Recombinant Adenoviruses Containing Anti-sense RNA Resists HIV-1 Infection on MT4 Cell Lines. Li, W.G., W.M. Nie, W.W. Chen, T.J. Jiang, X.Y. Xu, and M. Zhao. Gene, 2013. 526(2): p. 443-448. PMID[23510780].

[PubMed]. HIV_0830-091213.


10. Activity of the HIV-1 Attachment Inhibitor BMS-626529, the Active Component of the Prodrug BMS-663068, against CD4-independent Viruses and HIV-1 Envelopes Resistant to Other Entry Inhibitors. Li, Z., N. Zhou, Y. Sun, N. Ray, M. Lataillade, G.J. Hanna, and M. Krystal. Antimicrobial Agents and Chemotherapy, 2013. 57(9): p. 4172-4180. PMID[23774428].

[PubMed]. HIV_0830-091213.


11. Increase of anti-HIV Activity of C-peptide Fusion Inhibitors Using a Bivalent Drug Design Approach. Ling, Y., H. Xue, X. Jiang, L. Cai, and K. Liu. Bioorganic & Medicinal Chemistry Letters, 2013. 23(17): p. 4770-4773. PMID[23906421].

[PubMed]. HIV_0830-091213.


12. Substrate Envelope-designed Potent HIV-1 Protease Inhibitors to Avoid Drug Resistance. Nalam, M.N., A. Ali, G.S. Reddy, H. Cao, S.G. Anjum, M.D. Altman, N.K. Yilmaz, B. Tidor, T.M. Rana, and C.A. Schiffer. Chemistry & Biology, 2013. [Epub ahead of print]. PMID[24012370].

[PubMed]. HIV_0830-091213.


13. Generation of a Replication-competent Simianhuman Immunodeficiency Virus, the Neutralisation Sensitivity of Which Can Be Enhanced in the Presence of a Small Molecule CD4 Mimic. Otsuki, H., T. Hishiki, T. Miura, C. Hashimoto, T. Narumi, H. Tamamura, K. Yoshimura, S. Matsushita, and T. Igarashi. The Journal of General Virology, 2013. [Epub ahead of print]. PMID[24026672].

[PubMed]. HIV_0830-091213.


14. SIV Replication Is Directly Downregulated by Four Antiviral miRNAs. Sisk, J.M., K.W. Witwer, P.M. Tarwater, and J.E. Clements. Retrovirology, 2013. 10(1): p. 95. PMID[23988154].

[PubMed]. HIV_0830-091213.


15. 17β-Estradiol Inhibits HIV-1 by Inducing a Complex Formation between β-Catenin and Estrogen Receptor Alpha on the HIV Promoter to Suppress HIV Transcription. Szotek, E.L., S.D. Narasipura, and L. Al-Harthi. Virology, 2013. 443(2): p. 375-383. PMID[23769242].

[PubMed]. HIV_0830-091213.


16. Roles of the K101E Substitution in HIV-1 Reverse Transcriptase in Resistance to Rilpivirine and Other Non-Nucleoside Reverse Transcriptase Inhibitors. Xu, H.T., S.P. Colby-Germinario, W. Huang, M. Oliveira, Y. Han, Y. Quan, C.J. Petropoulos, and M.A. Wainberg. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[24002090].

[PubMed]. HIV_0830-091213.

ISI Web of Knowledge Citations

18. A Multi-targeted Drug Candidate with Dual anti-HIV and anti-HSV Activity. Balzarini, J., G. Andrei, E. Balestra, D. Huskens, C. Vanpouille, A. Introini, S. Zicari, S. Liekens, R. Snoeck, A. Holy, C.F. Perno, L. Margolis, and D. Schols. Plos Pathogens, 2013. 9(7): p. e1003456. ISI[000322316700015].

[WOS]. HIV_0830-091213.


19. Replication Fitness of Multiple Nonnucleoside Reverse Transcriptase-resistant HIV-1 Variants in the Presence of Etravirine Measured by 454 Deep Sequencing. Brumme, C.J., K.D. Huber, W. Dong, A.F.Y. Poon, P.R. Harrigan, and N. Sluis-Cremer. Journal of Virology, 2013. 87(15): p. 8805-8807. ISI[000321590200048].

[WOS]. HIV_0830-091213.


20. Lamivudine Salts with 1,2-Dicarboxylic acids: A New and a Rare Synthon with Double Pairing Motif Fine-tuning Their Solubility. da Silva, C.C., M.D. Cirqueira, and F.T. Martins. CrystEngComm, 2013. 15(32): p. 6311-6317. ISI[000322343700007].

[WOS]. HIV_0830-091213.


21. Synthesis and NMR Elucidation of Novel Pentacycloundecane-derived Peptides. Karpoormath, R., O.K. Onajole, T. Naicker, T. Govender, G.E.M. Maguire, and H.G. Kruger. South African Journal of Chemistry, 2012. 65: p. 108-114. ISI[000322108300009].

[WOS]. HIV_0830-091213.


22. Selection of Drug-resistant Feline Immunodeficiency Virus (FIV) Encoding FIV/HIV Chimeric Protease in the Presence of HIV-specific Protease Inhibitors. Lin, Y.C., M. Happer, and J.H. Elder. Journal of Virology, 2013. 87(15): p. 8524-8534. ISI[000321590200024].

[WOS]. HIV_0830-091213.


23. Emergence of gp120 V3 Variants Confers Neutralization Resistance in an R5 Simian-Human Immunodeficiency Virus-infected Macaque Elite Neutralizer That Targets the N332 Glycan of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein. Sadjadpour, R., O.K. Donau, M. Shingai, A. Buckler-White, S. Kao, K. Strebel, Y. Nishimura, and M.A. Martin. Journal of Virology, 2013. 87(15): p. 8798-8804. ISI[000321590200047].

[WOS]. HIV_0830-091213.


24. Ubiquitin Conjugation to Gag Is Essential for ESCRT-mediated HIV-1 Budding. Sette, P., K. Nagashima, R.C. Piper, and F. Bouamr. Retrovirology, 2013. 10 (1): p. 79. ISI[000323369500001].

[WOS]. HIV_0830-091213.


25. Retrovirus Restriction by TRIM5 Proteins Requires Recognition of Only a Small Fraction of Viral Capsid Subunits. Shi, J., D.B. Friedman, and C. Aiken. Journal of Virology, 2013. 87(16): p. 9271-9278. ISI[000322535600041].

[WOS]. HIV_0830-091213.


26. Automethylation of Protein Arginine Methyltransferase 6 (PRMT6) Regulates Its Stability and Its anti-HIV-1 Activity. Singhroy, D.N., T. Mesplede, A. Sabbah, P.K. Quashie, J.P. Falgueyret, and M.A. Wainberg. Retrovirology, 2013. 10. ISI[000322903200001].

[WOS]. HIV_0830-091213.


27. Analog of Somatostatin Vapreotide Exhibits Biological Effects in Vitro Via Interaction with Neurokinin-1 Receptor. Spitsin, S., F. Tuluc, J. Meshki, J.P. Lai, R. Tustin, and S.D. Douglas. NeuroImmunoModulation, 2013. 20(5): p. 247-255. ISI[000322891000002].

[WOS]. HIV_0830-091213.


28. New 23-Spirocholestane Derivatives from Ypsilandra thibetica. Xie, B.B., C.X. Chen, Y.H. Guo, Y.Y. Li, Y.J. Liu, W. Ni, L.M. Yang, N.B. Gong, Y.T. Zheng, R.R. Wang, Y. Lu, and H.Y. Liu. Planta Medica, 2013. 79(12): p. 1063-1067. ISI[000323178100011].

[WOS]. HIV_0830-091213.


29. Novel Intravaginal Nanomedicine for the Targeted Delivery of Saquinavir to CD4(+) Immune Cells. Yang, S.D., Y.F. Chen, K.E. Gu, A. Dash, C.L. Sayre, N.M. Davies, and E.A. Ho. International Journal of Nanomedicine, 2013. 8: p. 2847-2858. ISI[000322809900001].

[WOS]. HIV_0830-091213.


30. Molecular Design, Synthesis and Biological Evaluation of BP-O-DAPY and O-DAPY Derivatives as Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Yang, S.Q., C. Pannecouque, D. Daelemans, X.D. Ma, Y. Liu, F.E. Chen, and E. De Clercq. European Journal of Medicinal Chemistry, 2013. 65: p. 134-143. ISI[000322850100014].

[WOS]. HIV_0830-091213.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2022